-
FerroOrange Fe²⁺ Fluorescent Probe: Advanced Live Cell Iron
2026-05-20
FerroOrange, APExBIO’s Fe²⁺ fluorescent probe, delivers unrivaled sensitivity and specificity for live cell ferrous ion detection. This article demystifies experimental workflows, showcases troubleshooting strategies, and contextualizes FerroOrange’s strengths in cutting-edge iron metabolism and ferroptosis research.
-
ML216, BLM Helicase Inhibitor: Applied Protocols for Synthet
2026-05-20
ML216, a potent BLM helicase inhibitor from APExBIO, empowers researchers to dissect DNA repair vulnerabilities and model synthetic lethality in cancer. This guide delivers actionable workflows, troubleshooting insights, and data-backed protocol enhancements for maximizing ML216’s impact in cell-based and in vivo studies.
-
Acridine Orange hydrochloride: Technical Use in Nucleic Acid
2026-05-19
Acridine Orange hydrochloride is a membrane-permeable fluorescent dye optimized for differential staining of DNA and RNA in cytochemical workflows, including cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is not suitable for protocols requiring non-membrane-permeable dyes or long-term storage of working solutions. Following product-specific solubility and storage guidance is critical for reliable results.
-
Dimethyloxalylglycine (DMOG): Technical Use in Hypoxia Model
2026-05-19
Dimethyloxalylglycine (DMOG) is a cell-permeable inhibitor designed to stabilize hypoxia-inducible factors by inhibiting prolyl-4-hydroxylase enzymes, enabling the modeling of hypoxic signaling and immune regulation in controlled research settings. It should be used for in vitro and in vivo studies of oxygen sensing, hypoxia signaling, and inflammation—not for diagnostic or clinical applications.
-
YTHDF2 Inhibition Elevates Protein Synthesis and Memory Form
2026-05-18
This study demonstrates that forebrain-specific knockout of YTHDF2, a key m6A reader protein, leads to enhanced protein synthesis and improved hippocampus-dependent learning and memory in mice. The findings provide mechanistic insight into m6A-mediated mRNA degradation and its impact on synaptic plasticity, offering new directions for neuroepigenetic research and experimental workflows.
-
Cdk5 Downregulation Attenuates Hippocampal Neuron Ferroptosi
2026-05-18
This study demonstrates that inhibiting Cdk5 in murine models of ischemic stroke reverses neuronal ferroptosis by modulating the AMPK pathway and suppressing pro-inflammatory microglial polarization. These findings reveal mechanistic links between Cdk5, iron-dependent cell death, and neuroinflammation, highlighting new avenues for targeted neuroprotection.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn
2026-05-17
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses the critical challenge of protein degradation during extraction workflows, particularly where downstream applications require preservation of divalent cations. This solution is not suitable for workflows needing metalloprotease inhibition via EDTA or for systems intolerant of DMSO.
-
FerroOrange Fe²⁺ Fluorescent Probe: Live Cell Iron Detection
2026-05-16
FerroOrange, the Fe²⁺ fluorescent probe from APExBIO, delivers precise, real-time quantification of intracellular ferrous ions in living cells. Its robust workflow compatibility and high specificity make it indispensable for iron metabolism and ferroptosis research, especially in neurobiology.
-
Wnt Agonist 1 (BML-284): Precision in Wnt Pathway Research
2026-05-15
Wnt agonist 1 (BML-284) enables researchers to robustly activate the canonical Wnt signaling pathway, facilitating breakthroughs in cellular differentiation and chemoresistance studies. This article delivers workflow-driven guidance, data-backed protocol enhancements, and troubleshooting strategies that leverage APExBIO’s high-purity reagent for reproducible and advanced experimental outcomes.
-
Thapsigargin: SERCA Pump Inhibitor for Calcium Signaling Res
2026-05-15
Thapsigargin stands out as a benchmark SERCA pump inhibitor, enabling high-fidelity dissection of calcium signaling and endoplasmic reticulum stress responses in cellular and animal models. Its rapid, nanomolar-potency effects streamline apoptosis assays and mechanistic studies, with recent advances clarifying its role in overcoming ER stress resistance in glioblastoma.
-
EZH2 Inhibition as a Therapeutic Approach in HPV+ Cervical C
2026-05-14
This study demonstrates that selective EZH2 inhibitors, including EPZ-6438, induce apoptosis and cell cycle arrest in both HPV-positive and HPV-negative cervical cancer models. The findings support EZH2 inhibition as a promising, less toxic alternative to traditional chemotherapy for HPV-associated malignancies, with implications for epigenetic cancer research and translational therapy.
-
TPPU: Soluble Epoxide Hydrolase Inhibitor for Inflammatory P
2026-05-14
TPPU is redefining chronic inflammation research by enabling precise inhibition of soluble epoxide hydrolase, with proven nanomolar potency and robust pharmacokinetics in vivo. Its application extends from osteoclastogenesis assays to advanced inflammatory pain models, offering unmatched reproducibility and translational insight.
-
E-4031 in Translational Cardiac Research: Mechanistic Insigh
2026-05-13
Explore how E-4031, a potent hERG potassium channel blocker, enables deeper mechanistic insights and experimental design flexibility in cardiac electrophysiology research. This article uniquely dissects advanced applications, protocol parameters, and practical assay decision-making for translational science.
-
Acridine Orange hydrochloride: Practical Guide for Nucleic A
2026-05-13
Acridine Orange hydrochloride (SKU B7747) provides a dual-fluorescence, cell-permeable method for differential staining of DNA and RNA, supporting cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. This article outlines actionable parameters and workflow controls for reliable cytochemical applications. Use is limited to nucleic acid-related assays and is not recommended for long-term solution storage or unsupported mechanistic claims.
-
Erastin: A Benchmark Ferroptosis Inducer for Cancer Biology
2026-05-12
Erastin is a well-characterized ferroptosis inducer that triggers iron-dependent, non-apoptotic cell death in tumor cells with RAS or BRAF mutations. Its precise mechanism and robust selectivity make it indispensable for ferroptosis and cancer biology research. Protocols employing Erastin at 10 μM for 24 hours reliably induce ferroptosis in HT-1080 and engineered tumor cells.